The District of New Jersey has recently held that, under 35 U.S.C. § 271(e)(2), a court may exercise jurisdiction in a Hatch-Waxman Act case over claim of patent infringement where the Abbreviated New Drug Application filer did not make a Paragraph IV certification for that patent.